Clinical Researcher—March 2019 (Volume 33, Issue 3) EXECUTIVE DIRECTOR’S MESSAGE Jim Kremidas New technologies are impacting the clinical trial landscape in ways almost unimaginable 20 years ago. Whether it’s widespread […]
Clinical Researcher—March 2019 (Volume 33, Issue 3) RESEARCH COMPLIANCE Jan S. Peterson, MS, CCRA, RAC, ASQ CBA, ACRP-CP Q: My institution is currently in the process of amending its standard […]
“Study start-up timelines [had] been static for [many years] at about seven months. Now start-up timelines are even longer. The industry is trending slower,” says Ashley Davidson with Veeva Systems. […]
Quality is a state of mind. No, this isn’t a serene Zen master talking from atop a hill in Tibet. It’s Sergey Nikitin, BSc, MBA, president and director of Prime […]
In a surprise move, Scott Gottlieb, MD, Commissioner of the U.S. Food and Drug Administration (FDA), is leaving the agency in April, according to a report in The Washington Post. […]